Concepedia

Judith N. Steenbergen

JN

45

Publications

4K

Citations

31

H-Index

1977

Active since

Affiliations

Cubist Pharmaceuticals (United States)(Current)

Paratek Pharmaceuticals (United States)

JMI Laboratories

Institute for Clinical Pharmacodynamics (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Judith N. Steenbergen is an author at Cubist Pharmaceuticals (United States) specializing in medicine, clinical microbiology, and health sciences.

Top concepts

Publications per year

1977–2023

45

Publications

45

<i>Cryptococcus neoformans</i> interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages

Judith N. Steenbergen, Howard A. Shuman, Arturo Casadevall · Proceedings of the National Academy of Sciences · 2001 · 518 citations · Full text

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

Joseph S. Solomkin, Ellie Hershberger, Benjamin Miller et al. · Clinical Infectious Diseases · 2015 · 400 citations · Full text

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)

Florian Wagenlehner, Obiamiwe Umeh, Judith N. Steenbergen et al. · The Lancet · 2015 · 372 citations

, , +6

Omadacycline for Community-Acquired Bacterial Pneumonia

Roman Stets, Monica Popescu, Joven Gonong et al. · New England Journal of Medicine · 2019 · 215 citations · Full text

Daptomycin Rapidly Penetrates a <i>Staphylococcus epidermidis</i> Biofilm

Philip S. Stewart, William M. Davison, Judith N. Steenbergen · Antimicrobial Agents and Chemotherapy · 2009 · 186 citations · Full text

, , +14

Rows per page

1–5 of 45